Quoted Micro 27 July 2026
AQUIS STOCK EXCHANGE Arbuthnot Banking (ARBB) had a good first half performance and expectations have been upgraded. Interim pre-tax profit was flat and financial headroom remains comfortable. Improved efficiency helped to maintain profit when interest rates were lower. Specialist lending grew 18%. There is growth in the core businesses, but higher technology costs offset this […]
Quoted Micro 25 May 2026
AQUIS STOCK EXCHANGE Time to ACT (TTA) says that Ruth Herbert has been appointed chief executive of EET Hydrogen and power, which is a potential client, and final investment decision for the HPP1 blue hydrogen project is due in the second half of 2026. Time to ACT has completed the acquisition of MTE Heat Treatment […]
Quoted Micro 30 March 2026
AQUIS STOCK EXCHANGE Executive recruiter Connecting Excellence (XCE) increased net fee income by one-fifth to £890,000 in the six months to December 2025. There was cash of £1.4m and Bitcoin holdings of £2.62m (40.36 Bitcoin). Net fee income in January was £250,000. The Bitcoin holding has increased to 52.42 Bitcoin. Residential property developer Zentra (ZNT) […]
Quoted Micro 16 March 2026
AQUIS STOCK EXCHANGE Marula Mining (MARU) is still investigating various sources of additional finance. The directors and related parties are providing funding. An $8m copper concentrate purchase agreement has been secured with a New York company. This covers 2,500 tonnes of copper concentrate each month from the Kinusi copper mine. The 2024 accounts have still […]
Quoted Micro 23 February 2026
AQUIS STOCK EXCHANGE Cooks Coffee Company (COOK) says its UK Esquires coffee stores generated revenues of £21.9m in the nine months to December 2025, while sales in Ireland were 27% higher at £9.9m. There was like-for-like growth of 5.1% and 6.3% respectively. Income comes predominantly from franchise fees and royalties. Delta Gold Technologies (DGQ), the […]
Quoted Micro 28 July 2025
AQUIS STOCK EXCHANGE Arbuthnot Banking (ARBB) reported a slump in pre-tax profit from £20.8m to £10.9m, despite lower than expected impairments. The interim dividend was raised by 10% to 22p/share. NAV is 1649p/share. Shore has reduced its full year pre-tax profit forecast from £28.5m to £25.9m. Gledhow Investments (GDH) has withdrawn the general meeting resolution […]
Quoted Micro 26 May 2025
AQUIS STOCK EXCHANGE Arbuthnot Banking Group (ARBB) stated at the AGM that trading was in line with expectations in the first four months of the year. Activity is showing signs of picking up. There were loan and lease assts of £2.36bn at the end of April 2025. Deposits rose 3% to £4.26bn. There was an […]
Quoted Micro 24 February 2025
AQUIS STOCK EXCHANGE Aquis-quoted healthcare procedures supplier One Health Group (OHGR) plans to move to AIM. As part of the process, it raised £5.2m from a placing at 180p/share and existing shareholders have the chance to take up shares in an open offer of up to £500,000. A WRAP retail offer could raise up to £500,000 […]
Quoted Micro 2 December 2024
AQUIS STOCK EXCHANGE Incanthera (INC) has been accused of potential patent infringement in the formulation of its Skin + Cell skincare range. Even though Incanthera believes that there is no merit to the accusation, but the launch of the Skin + Cell range of products has been delayed. There is cash in the bank following […]
Quoted Micro 21 October 2024
AQUIS STOCK EXCHANGE ProBiotix Health (PBX) has sent out a circular for the requisitioned general meeting on 1 November. The meeting has been requisitioned by Seneca Partners and related investors that hold 5.46% in total. Seneca Partners is also an investor in AIM-quoted OptiBiotix Health (LON: OPTI), which is also unhappy with the current management, […]